Hospira irinotecan hydrochloride trihydrate IV Infusion 100 mg

Šalis: Australija

kalba: anglų

Šaltinis: Department of Health (Therapeutic Goods Administration)

Veiklioji medžiaga:

irinotecan hydrochloride trihydrate, Quantity: 20 mg/mL

Prieinama:

Hospira Australia Pty Ltd

INN (Tarptautinis Pavadinimas):

irinotecan hydrochloride trihydrate

Vaisto forma:

Injection, intravenous infusion

Sudėtis:

Excipient Ingredients: lactic acid; sorbitol; water for injections

Vartojimo būdas:

Intravenous Infusion

Vienetai pakuotėje:

1 x 5 mL vial

Klasė:

Medicine Listed (Export Only)

Recepto tipas:

(S1) This Schedule is intentionally blank

Terapinės indikacijos:

Small cell lung carcinoma, non-small cell lung carcinoma, cervical carcinoma, ovarian cancer, stomach cancer (inoperable or recurrent), colorectal cancer (inoperable or recurrent), breast cancer (inoperable or recurrent), squamous cell carcinoma, malignant lymphoma (non Hodgkin's disease).

Produkto santrauka:

Visual Identification: A clear, colourless to pale yellow solution; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 36 Months; Container Temperature: Room temperature; Container Closure: Neither child resistant closure nor restricted flow insert

Autorizacija statusas:

Licence status A

Leidimo data:

2013-01-31